tenk.fyi

Quince Therapeutics, Inc.

QNCXNasdaq· Biological Products, (No Diagnostic Substances)

Price History

Revenue

-

Net Income

-$56.8M

81.1% YoY

EPS

$-1.31

56.0% YoY

Cash

$40.8M

96.6% YoY

FY 2024 · As of 2024-12-31